Navigation Links
Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
Date:9/22/2009

Medelis, an oncology contract research organization in the US and Europe, is expanding its services to support medical devices under the guidance of Inder Makin, M.D., Ph.D., who joins the company as Vice President, Devices & Radiological Health. Medelis will support medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies. The company will also collaborate with clients to help them gain regulatory and marketing approvals.

Phoenix, AZ (PRWEB) September 22, 2009 -- Medelis, Inc., a full-service oncology contract research organization (CRO) in the US and Europe, today announced that the company is expanding its services to support medical devices under the guidance of Inder Makin, M.D., Ph.D., who joins the company as Vice President, Devices & Radiological Health.

Dr. Makin has more than 20 years of experience developing "concept to clinic" healthcare technologies in both academia and industry. He has developed medical ultrasound-based research programs at various institutes, taking concepts (including catheter-based devices for intravascular thrombolysis, transdermal drug delivery devices and non-invasive and intracorporeal tissue ablation devices) through feasibility and launch.

"We are extremely pleased to add Dr. Makin to our team of experts," said Medelis President & CEO Bob Bosserman. "His unique combination of medical and biomedical engineering expertise enables him to assist our clients in effectively developing and refining new device solutions for patients. He will also provide invaluable guidance in helping them obtain marketing approvals for successful commercialization."

Medelis will support medical device manufacturers throughout the product life cycle including early design and prototyping, simulation, preclinical and phase I-III clinical studies. The company will also collaborate with clients to help them gain regulatory and marketing approvals.

About Inder Makin, M.D., Ph.D.

During the past 20 years, Dr. Inder Makin has been active in strategy development and implementation of medical device technology from lab to market. He is a co-founder of Guided Therapy Systems, LLC (VP Applications and Clinical Development), Ulthera, Inc. and Xthetix, Inc. (VP Clinical and Application Development). Scientifically, he has been involved in the basic and applied research of ultrasound-tissue interaction, sound-bubble interaction and propagation of high-intensity ultrasound through tissue-like media. He has published more than 20 scientific papers, chaired various national and international conferences, and holds 8 patents. He received his M.D. from Jiwaji University, India in 1985, Diplom Ingenieur in Biomedical Engineering from Fachhochschule Hamburg, Germany, and his Ph.D. in Biomedical Engineering from Univ. of Texas at Austin, with specialization in nonlinear and medical acoustics. He is also an accredited medical sonographer (RDMS).

About Medelis

Medelis, Inc. is an oncology contract research organization providing a total solution for biotechnology and pharmaceutical companies seeking rapid drug development and approval. Medelis' medical founders, team physicians and clinical trial management physicians, including Dan Von Hoff, James Gourzis and Michael Gordon, are internationally-recognized oncology thought and opinion leaders who understand the future of personalized medicine and threshold of credibility trials. Medelis also supports medical device manufacturers from early design through regulatory approval.

Medelis is privately-held with US locations in Phoenix (headquarters), Nashville, Boston and Reno. The company's European CRO services are headquartered in Port Vendres, France.

# # #

Read the full story at http://www.prweb.com/releases/contractresearch/medicaldevices/prweb2902524.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medelis Expands CRO Services to Medical Devices, Appoints Dr. Inder Makin as VP
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):